Effect of Preoperative Oral Pregabalin as an Adjunct to Multimodal Analgesic Regimen in shoulder arthroscopic surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0000578

Enrollment

Registered

2012-11-14

Start date

2012-10-18

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Control group received placebo orally 1 hr before the anesthetic induction Pregabalin groups received pregabalin 150 mg orally 1 hour before the anesthetic induction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 60 patients (20-65 yr) scheduled for elective shoulder arthroscopic surgery

Exclusion criteria

Exclusion criteria: patients of ASA classification 3 or more, with a history of cardiovascular or respiratory disease dizziness or frequent headache history active alcohol or drug usage history daily intake or intake 48 hr preoperatively of any analgesics impaired renal and/or hepatic function inability to use a PCA device

Design outcomes

Primary

Measure	Time frame
Total volume of administered IV PCA	—

Secondary

Measure	Time frame
rescue analgesics;VAS (visual analogue scale);incidence and severity of adverse effects induced by IV PCA;incidence of adverse effects induced by pregabalin	—

Countries

Korea, Republic of

Contacts

Public ContactSung-Hye Byun

Kyungpook National University Hospital

stone0311@naver.com+82-53-200-3494

Outcome results